662 related articles for article (PubMed ID: 33572160)
1. Post-Translational Modifications That Drive Prostate Cancer Progression.
Samaržija I
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572160
[TBL] [Abstract][Full Text] [Related]
2. Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.
Padmanabhan A; Rao V; De Marzo AM; Bieberich CJ
Prostate; 2016 May; 76(6):523-33. PubMed ID: 26841725
[TBL] [Abstract][Full Text] [Related]
3. Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.
Chen Z; Lu W
Int J Mol Sci; 2015 Feb; 16(3):4560-80. PubMed ID: 25734985
[TBL] [Abstract][Full Text] [Related]
4. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
5. Post-translational modifications of the progesterone receptors.
Abdel-Hafiz HA; Horwitz KB
J Steroid Biochem Mol Biol; 2014 Mar; 140():80-9. PubMed ID: 24333793
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modification of the androgen receptor.
Gioeli D; Paschal BM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modification and regulation of actin.
Terman JR; Kashina A
Curr Opin Cell Biol; 2013 Feb; 25(1):30-8. PubMed ID: 23195437
[TBL] [Abstract][Full Text] [Related]
8. Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code.
Wang Y; Wang F
Front Pharmacol; 2021; 12():685011. PubMed ID: 34177595
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of Flotillin-1 promotes EMT in metastatic prostate cancer by suppressing Snail degradation.
Jang D; Kwon H; Choi M; Lee J; Pak Y
Oncogene; 2019 Apr; 38(17):3248-3260. PubMed ID: 30631151
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications: Regulators of neurodegenerative proteinopathies.
Gupta R; Sahu M; Srivastava D; Tiwari S; Ambasta RK; Kumar P
Ageing Res Rev; 2021 Jul; 68():101336. PubMed ID: 33775891
[TBL] [Abstract][Full Text] [Related]
11. Aberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injury.
Osna NA; Carter WG; Ganesan M; Kirpich IA; McClain CJ; Petersen DR; Shearn CT; Tomasi ML; Kharbanda KK
World J Gastroenterol; 2016 Jul; 22(27):6192-200. PubMed ID: 27468209
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Regulation of Chromatin in Prostate Cancer.
Natesan R; Aras S; Effron SS; Asangani IA
Adv Exp Med Biol; 2019; 1210():379-407. PubMed ID: 31900918
[TBL] [Abstract][Full Text] [Related]
13. Post-translational and transcriptional dynamics - regulating extracellular vesicle biology.
Claridge B; Kastaniegaard K; Stensballe A; Greening DW
Expert Rev Proteomics; 2019 Jan; 16(1):17-31. PubMed ID: 30457403
[No Abstract] [Full Text] [Related]
14. Protein Modification and Autophagy Activation.
Wang R; Wang G
Adv Exp Med Biol; 2019; 1206():237-259. PubMed ID: 31776989
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Mechanisms and Posttranslational Modifications in Systemic Lupus Erythematosus.
Navarro Quiroz E; Chavez-Estrada V; Macias-Ochoa K; Ayala-Navarro MF; Flores-Aguilar AS; Morales-Navarrete F; de la Cruz Lopez F; Gomez Escorcia L; Musso CG; Aroca Martinez G; Gonzales Torres H; Diaz Perez A; Cadena Bonfanti A; Sarmiento Gutierrez J; Meza J; Diaz Arroyo E; Bello Lemus Y; Ahmad M; Navarro Quiroz R
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766160
[TBL] [Abstract][Full Text] [Related]
16. Post-Translational Modifications of Transcription Factors Harnessing the Etiology and Pathophysiology in Colonic Diseases.
Hsu CY; Fu SH; Chien MW; Liu YW; Chen SJ; Sytwu HK
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32369982
[TBL] [Abstract][Full Text] [Related]
17. Post-translational modifications in bladder cancer: Expanding the tumor target repertoire.
Oo HZ; Seiler R; Black PC; Daugaard M
Urol Oncol; 2020 Dec; 38(12):858-866. PubMed ID: 30342880
[TBL] [Abstract][Full Text] [Related]
18. Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications.
Zenata O; Vrzal R
Oncotarget; 2017 May; 8(21):35390-35402. PubMed ID: 28427151
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications and immune responses in liver cancer.
Wang YW; Zuo JC; Chen C; Li XH
Front Immunol; 2023; 14():1230465. PubMed ID: 37609076
[TBL] [Abstract][Full Text] [Related]
20. The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer.
Pellegrino NE; Guven A; Gray K; Shah P; Kasture G; Nastke MD; Thakurta A; Gesta S; Vishnudas VK; Narain NR; Kiebish MA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
